3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Neoplasms
1
Melanoma
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Adenocarcinoma
1
Carcinoma, Hepatocellular
1
Adenomatous Polyposis Coli
1
Interventions
Metformin
35
Clomiphene
11
Letrozole
10
Inositol
7
Triptorelin Pamoate
5
drospirenone and ethinyl estradiol combination
4
Progesterone
4
Folic Acid
4
Ethinyl Estradiol
4
Caloric Restriction
4
drospirenone
3
cetrorelix
3
Spironolactone
3
Estradiol
3
Diet, Mediterranean
3
Diet
3
Cyproterone acetate, ethinyl estradiol drug combination
3
Contraceptives, Oral
3
Acupuncture Therapy
3
adrenosterone
2
Vitamin D
2
Ultrasonography
2
Thioctic Acid
2
Therapeutics
2
Sitagliptin Phosphate
2
Simvastatin
2
Pioglitazone
2
Ovidrel
2
Musculoskeletal Manipulations
2
Hematologic Tests
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Polycystic Ovary Syndrome
×
Pharmaceutical Preparations
×
Clear all
NCT02244567
2021-02-02
U-C OC IN PCOS
Beni-Suef University
Phase 1
Unknown
100 enrolled